BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 26106966)

  • 1. Risk of congenital anomalies associated with antithyroid treatment during pregnancy: a meta-analysis.
    Li X; Liu GY; Ma JL; Zhou L
    Clinics (Sao Paulo); 2015 Jun; 70(6):453-9. PubMed ID: 26106966
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Birth defects after early pregnancy use of antithyroid drugs: a Danish nationwide study.
    Andersen SL; Olsen J; Wu CS; Laurberg P
    J Clin Endocrinol Metab; 2013 Nov; 98(11):4373-81. PubMed ID: 24151287
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Risk of adverse perinatal outcomes with antithyroid treatment during pregnancy: a nationwide population-based study.
    Chen CH; Xirasagar S; Lin CC; Wang LH; Kou YR; Lin HC
    BJOG; 2011 Oct; 118(11):1365-73. PubMed ID: 21624036
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Timing of Shift in Antithyroid Drug Therapy and Birth Defects.
    Andersen SL; Andersen S
    Thyroid; 2019 Jan; 29(1):155-156. PubMed ID: 30458113
    [No Abstract]   [Full Text] [Related]  

  • 5. Treatment of hyperthyroidism in pregnancy and birth defects.
    Clementi M; Di Gianantonio E; Cassina M; Leoncini E; Botto LD; Mastroiacovo P;
    J Clin Endocrinol Metab; 2010 Nov; 95(11):E337-41. PubMed ID: 20668039
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of the safety between propylthiouracil and methimazole with hyperthyroidism in pregnancy: A systematic review and meta-analysis.
    Liu Y; Li Q; Xu Y; Chen Y; Men Y
    PLoS One; 2023; 18(5):e0286097. PubMed ID: 37205692
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy of propylthiouracil in the treatment of pregnancy with hyperthyroidism and its effect on pregnancy outcomes: A meta-analysis.
    Miao Y; Xu Y; Teng P; Wang A; Zhang Y; Zhou Y; Liu W
    PLoS One; 2022; 17(3):e0265085. PubMed ID: 35271661
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacologic treatment of hyperthyroidism during pregnancy.
    Cassina M; DonĂ  M; Di Gianantonio E; Clementi M
    Birth Defects Res A Clin Mol Teratol; 2012 Aug; 94(8):612-9. PubMed ID: 22511519
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Management of Hyperthyroidism during the Preconception Phase, Pregnancy, and the Postpartum Period.
    Sarkar S; Bischoff LA
    Semin Reprod Med; 2016 Nov; 34(6):317-322. PubMed ID: 27741549
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antithyroid drug therapy in pregnancy and risk of congenital anomalies: Systematic review and meta-analysis.
    Agrawal M; Lewis S; Premawardhana L; Dayan CM; Taylor PN; Okosieme OE
    Clin Endocrinol (Oxf); 2022 Jun; 96(6):857-868. PubMed ID: 34845757
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Safety of antithyroid drugs in pregnancy: update and therapy implications.
    Francis T; Francis N; Lazarus JH; Okosieme OE
    Expert Opin Drug Saf; 2020 May; 19(5):565-576. PubMed ID: 32223355
    [No Abstract]   [Full Text] [Related]  

  • 12. Treatment of hyperthyroidism in pregnancy with propylthiouracil and methimazole.
    Mujtaba Q; Burrow GN
    Obstet Gynecol; 1975 Sep; 46(3):282-6. PubMed ID: 51489
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The use of antithyroid drugs should be reduced as much as possible in the first trimester].
    Andersen SL; Laurberg P
    Ugeskr Laeger; 2014 Sep; 176(39):. PubMed ID: 25294327
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of methimazole and propylthiouracil exposure during pregnancy on the risk of neonatal congenital malformations: A meta-analysis.
    Song R; Lin H; Chen Y; Zhang X; Feng W
    PLoS One; 2017; 12(7):e0180108. PubMed ID: 28671971
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The safety of methimazole and propylthiouracil in pregnancy: a systematic review.
    Hackmon R; Blichowski M; Koren G
    J Obstet Gynaecol Can; 2012 Nov; 34(11):1077-1086. PubMed ID: 23231846
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antithyroid drug use during pregnancy and the risk of birth defects in offspring: systematic review and meta-analysis of observational studies with methodological considerations.
    Morales DR; Fonkwen L; Nordeng HME
    Br J Clin Pharmacol; 2021 Oct; 87(10):3890-3900. PubMed ID: 33783857
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Severity of birth defects after propylthiouracil exposure in early pregnancy.
    Andersen SL; Olsen J; Wu CS; Laurberg P
    Thyroid; 2014 Oct; 24(10):1533-40. PubMed ID: 24963758
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Therapy of hypo- and hyperthyroidism in pregnancy].
    Lind P
    Acta Med Austriaca; 1997; 24(4):157-8. PubMed ID: 9441554
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Effects of maternal hyperthyroidism and antithyroid drug therapy on congenital malformation of newborn infants].
    Lian XL; Bai Y; Xu YH; Dai WX; Guo ZS
    Zhonghua Fu Chan Ke Za Zhi; 2005 Aug; 40(8):511-5. PubMed ID: 16202286
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of graves' disease with antithyroid drugs in the first trimester of pregnancy and the prevalence of congenital malformation.
    Yoshihara A; Noh J; Yamaguchi T; Ohye H; Sato S; Sekiya K; Kosuga Y; Suzuki M; Matsumoto M; Kunii Y; Watanabe N; Mukasa K; Ito K; Ito K
    J Clin Endocrinol Metab; 2012 Jul; 97(7):2396-403. PubMed ID: 22547422
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.